New onset, post-op atrial fibrillation ups mortality

New onset, post-op atrial fibrillation ups mortality

(HealthDay)—New onset postoperative atrial fibrillation (POAF) is associated with worse patient outcomes, including increased risk-adjusted mortality, according to a study published in the August issue of The Annals of Thoracic Surgery.

Damien J. LaPar, M.D., from the University of Virginia in Charlottesville, and colleagues examined the risk-adjusted impact of POAF. They extracted 49,264 patient records from a multi-institutional Society of Thoracic Surgeons (STS) certified database for cardiac operations, performed from 2001 to 2012, and characterized them according to the presence of POAF (19 percent) versus non-POAF (81 percent).

The researchers found that patients who developed POAF had higher mean age and median STS-predicted mortality risk (2 versus 1 percent; P < 0.001), compared with non-POAF patients. Patients undergoing plus grafting, aortic valve, and mitral valve replacement operations had the highest rate of POAF. POAF correlated with increased odds of mortality (adjusted odds ratio, 2.04; P < 0.001); greater hospital resource utilization; and increased costs after risk adjustment. In addition, POAF correlated with 48 additional hours, three extra hospital days, and increased intensive care unit and total hospital-related costs ($3,000 and $9,000, respectively; all P < 0.001).

"Protocols to reduce the incidence of POAF have the potential to significantly impact and the delivery of high-quality, cost-effective patient care," the authors write.

One author disclosed financial ties to the medical device industry.

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

Risk for nonelective thoracic aortic sx up for uninsured

Apr 16, 2014

(HealthDay)—Uninsured patients have an increased risk of nonelective thoracic aortic operations, and have increased risks of major morbidity or mortality, according to a study published online April 8 in ...

Recommended for you

Use of drug-eluting stents may cut in-hospital mortality

Nov 20, 2014

(HealthDay)—Use of drug-eluting stents (DES) rather than bare-metal stents (BMS) for percutaneous coronary intervention (PCI) is associated with lower rates of in-hospital mortality, according to research ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.